Marker Therapeutics, Inc. (MRKR)
2.00
-0.07
(-3.38%)
USD |
NASDAQ |
Jan 09, 16:00
2.05
+0.05
(+2.50%)
After-Hours: 20:00
Marker Therapeutics Accounts Payable (Quarterly): 0.951M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 24.02M |
| Viridian Therapeutics, Inc. | 10.06M |
| Neurocrine Biosciences, Inc. | 119.90M |
| Kiniksa Pharmaceuticals International Plc | 6.15M |
| AIM ImmunoTech, Inc. | 1.252M |